v3.22.4
Condensed Consolidated Statements of Shareholders' Equity - USD ($)
$ in Thousands
Total
Common Shares
Additional  Paid-In Capital
Accumulated Deficit
Accumulated Other Comprehensive Loss
Beginning balance (in shares) at Mar. 31, 2021   283,130,000      
Beginning balance at Mar. 31, 2021 $ 1,113,601 $ 283 $ 1,653,328 $ (513,799) $ (26,211)
Increase (Decrease) in Partners' Capital [Roll Forward]          
Foreign currency translation 1,428       1,428
Restricted stock units vested (in shares)   1,049,000      
Restricted stock units vested 0 $ 1 (1)    
Restricted stock awards forfeited (in shares)   (19,000)      
Issuance of common stock related to employee stock purchase plan (in shares)   372,000      
Issuance of common stock related to employee stock purchase plan 13,914 $ 1 13,913    
Exercise of stock options (in shares)   1,170,000      
Exercise of stock options 23,651 $ 1 23,650    
Share-based compensation 71,950   71,950    
Equity repurchases (51)   (51)    
Net income 51,522     51,522  
Ending balance (in shares) at Dec. 31, 2021   285,702,000      
Ending balance at Dec. 31, 2021 1,276,015 $ 286 1,762,789 (462,277) (24,783)
Beginning balance (in shares) at Sep. 30, 2021   285,025,000      
Beginning balance at Sep. 30, 2021 1,221,002 $ 285 1,723,056 (476,864) (25,475)
Increase (Decrease) in Partners' Capital [Roll Forward]          
Foreign currency translation 692       692
Restricted stock units vested (in shares)   252,000      
Issuance of common stock related to employee stock purchase plan (in shares)   168,000      
Issuance of common stock related to employee stock purchase plan 7,321 $ 1 7,320    
Exercise of stock options (in shares)   257,000      
Exercise of stock options 5,311   5,311    
Share-based compensation 27,123   27,123    
Equity repurchases (21)   (21)    
Net income 14,587     14,587  
Ending balance (in shares) at Dec. 31, 2021   285,702,000      
Ending balance at Dec. 31, 2021 $ 1,276,015 $ 286 1,762,789 (462,277) (24,783)
Beginning balance (in shares) at Mar. 31, 2022 286,053,276 286,053,000      
Beginning balance at Mar. 31, 2022 $ 1,304,446 $ 286 1,792,197 (461,348) (26,689)
Increase (Decrease) in Partners' Capital [Roll Forward]          
Foreign currency translation (2,835)       (2,835)
Restricted stock units vested (in shares)   1,727,000      
Restricted stock units vested 0 $ 2 (2)    
Restricted stock awards forfeited (in shares)   (15,000)      
Issuance of common stock related to employee stock purchase plan (in shares)   553,000      
Issuance of common stock related to employee stock purchase plan $ 17,806   17,806    
Exercise of stock options (in shares) 643,000 643,000      
Exercise of stock options $ 15,102 $ 1 15,101    
Share-based compensation 104,853   104,853    
Equity repurchases (15)   (15)    
Net income $ 27,666     27,666  
Ending balance (in shares) at Dec. 31, 2022 288,961,064 288,961,000      
Ending balance at Dec. 31, 2022 $ 1,467,023 $ 289 1,929,940 (433,682) (29,524)
Beginning balance (in shares) at Sep. 30, 2022   287,813,000      
Beginning balance at Sep. 30, 2022 1,401,677 $ 288 1,874,488 (448,708) (24,391)
Increase (Decrease) in Partners' Capital [Roll Forward]          
Foreign currency translation (5,133)       (5,133)
Restricted stock units vested (in shares)   463,000      
Restricted stock awards forfeited (in shares)   (1,000)      
Issuance of common stock related to employee stock purchase plan (in shares)   287,000      
Issuance of common stock related to employee stock purchase plan 9,179   9,179    
Exercise of stock options (in shares)   399,000      
Exercise of stock options 10,770 $ 1 10,769    
Share-based compensation 35,504   35,504    
Net income $ 15,026     15,026  
Ending balance (in shares) at Dec. 31, 2022 288,961,064 288,961,000      
Ending balance at Dec. 31, 2022 $ 1,467,023 $ 289 $ 1,929,940 $ (433,682) $ (29,524)